Hypercoagulability in cirrhosis: causes and consequences.
about
Therapeutic and clinical aspects of portal vein thrombosis in patients with cirrhosisThrombosis Associated with Viral HepatitisEtiology and Complications of Portal Vein ThrombosisWhat we should know about portal vein thrombosis in cirrhotic patients: a changing perspectiveDifferential in vitro inhibition of thrombin generation by anticoagulant drugs in plasma from patients with cirrhosisChanging Concepts of Cirrhotic Coagulopathy.Portal vein thrombosis: When to treat and how?NF-E2 p45 is important for establishing normal function of platelets.Deep vein thrombosis and pulmonary embolism in cirrhotic patients: systematic review.Natural course of nonmalignant partial portal vein thrombosis in cirrhotic patients.Epidemiology of venous thromboembolism in patients with liver diseases: a systematic review and meta-analysis.Coagulation-driven platelet activation reduces cholestatic liver injury and fibrosis in mice.Procoagulant changes in fibrin clot structure in patients with cirrhosis are associated with oxidative modifications of fibrinogen.The international normalized ratio does not reflect bleeding risk in esophageal variceal hemorrhage.Autoimmune conditions are associated with perioperative thrombotic complications in liver transplant recipients: A UNOS database analysis.Presence of atrial fibrillation is associated with liver stiffness in an elderly Finnish population.Hepatocyte tissue factor contributes to the hypercoagulable state in a mouse model of chronic liver injury.Risk Factors for Portal Vein Thrombosis in Patients With Cirrhosis Awaiting Liver Transplantation in Shiraz, IranUsing an Electronic Medical Records Database to Identify Non-Traditional Cardiovascular Risk Factors in Nonalcoholic Fatty Liver Disease.Evaluation of coagulation parameters and liver enzymes among alcohol drinkers in Port Harcourt, NigeriaPortal vein thrombosis in liver cirrhosis.Blood component support in acquired coagulopathic conditions: is there a method to the madness?Management of anticoagulation for portal vein thrombosis in individuals with cirrhosis: a systematic review.Imaging in clinical decision-making for portal vein thrombosis.The emerging roles of microvesicles in liver diseases.Management of coagulation abnormalities in liver disease.The coagulation system in patients with end-stage liver disease.Managing complications in cirrhotic patientsPortal vein thrombosis in cirrhosis.Actions of thrombin in the interstitium.Acute-on-chronic liver failure: Pathogenesis, prognostic factors and management.Platelet-derived microparticles regulates thrombin generation via phophatidylserine in abdominal sepsis.Hepatobiliary quiz (answers)-13 (2015).Rac1 regulates bacterial toxin-induced thrombin generation.Impact of anticoagulation on upper-gastrointestinal bleeding in cirrhosis. A retrospective multicenter study.Monocytes regulate systemic coagulation and inflammation in abdominal sepsis.Thromboelastometry: Relation to the severity of liver cirrhosis in patients considered for liver transplantation.Bile Acids Do Not Contribute to the Altered Calcium Homeostasis of Platelets from Rats with Biliary Cirrhosis.Portal vein thrombosis in cirrhosis: Controversies and latest developments.Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome.
P2860
Q26774531-AB7B4103-5173-430B-9FD9-7E49C7850942Q26781784-D2D9DCC1-00D4-4215-9E4F-B99AD35DBB01Q26796515-6B1AB3F6-7B04-4E2A-BE8E-26F8A8AC78ACQ26827793-F290C1D4-F4C0-463B-9447-BEC19373D8D3Q28539503-D8AB046D-D6CE-4173-9284-3284FE78AA13Q30275544-C5742255-6907-40BB-8E54-604F87144474Q30278059-69BA6559-568F-4AB3-852F-00A616DF7D13Q33407515-70151181-73FC-4E53-9A19-441B3042E81CQ33626817-78B74AE7-2AE6-4A58-A0A0-EC5658E21608Q34335286-91B42F37-12D1-479B-9356-6315A3C8531AQ35486931-5D467546-F434-4F72-B4C8-43F9BF087956Q35806023-2F53821F-9663-40AE-961E-8F45232A7EA3Q35911484-C0665229-613D-4122-8830-43CE81BB6114Q35973813-FD0C42F7-6EB6-4C9B-9FCF-722016493E62Q36024830-738FB2A5-45BA-4627-BE3A-30216939A6D0Q36306317-6DB34B29-FBA7-4660-BF36-08F63E7C9C29Q36405104-F739C000-ACE5-4768-BCC7-4B1F2A0148E7Q36654381-22C9E159-63D8-4CCE-A64A-FFC777C9C111Q36892592-88FD4601-7D25-43E0-B91D-1C1A2A620C49Q36936892-DBF370B4-95EA-45F9-9E49-982985B8C251Q37603061-61AEDBDE-DF74-4CDA-9900-B432F20A56CCQ37999723-DE175F41-1754-4B21-B1BB-5E208FB3E3C5Q38025113-77559830-C151-409D-B833-7AB650992F47Q38178081-25FDE1E7-C4EF-4FC4-8EF4-FF409F48A0D3Q38184831-40CCBE5C-AC46-4415-84E3-2189981C8906Q38223728-E4951506-EAF6-49F4-BDCD-48FE56523B64Q38295874-97DF867B-1071-4751-9FF3-9DF9F2E0E70AQ38344890-9466ECE8-6594-4741-B649-AEA3C85F5E44Q38371574-07721C98-E59E-499E-88FA-CBC831797415Q38632366-02B78A56-F443-4E2F-AFE0-46DB67583E13Q38635623-DA9437B2-241E-43BD-8A88-27A1CCE6F860Q38836975-2BE7C33F-FCB5-4062-917B-BA5521F84FD3Q40112074-92E8F267-BE6D-4FC1-B198-2497B082D0B1Q40792797-8DC9D842-D391-4E4B-89CC-CAA845F06890Q41216205-A43E0CA1-F6F1-4B39-9F5F-D8FA66252630Q41602019-EE948ECA-DF20-45C8-9FC1-AE8D4E94CE5BQ42039361-758B5220-3906-4BC0-B3E0-5247A07FAE67Q42218317-57556884-61B7-41B9-A381-B3B776F88F1EQ42533695-B5E0BFBE-930A-44D0-ADE5-01426948E37DQ42627754-5F170D75-982D-4B4C-B868-F73186D75F0F
P2860
Hypercoagulability in cirrhosis: causes and consequences.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Hypercoagulability in cirrhosis: causes and consequences.
@ast
Hypercoagulability in cirrhosis: causes and consequences.
@en
type
label
Hypercoagulability in cirrhosis: causes and consequences.
@ast
Hypercoagulability in cirrhosis: causes and consequences.
@en
prefLabel
Hypercoagulability in cirrhosis: causes and consequences.
@ast
Hypercoagulability in cirrhosis: causes and consequences.
@en
P2093
P1476
Hypercoagulability in cirrhosis: causes and consequences
@en
P2093
K K Sogaard
M Primignani
P304
P356
10.1111/J.1538-7836.2011.04429.X
P577
2011-09-01T00:00:00Z